| Schedule of earnings per share |
| Schedule of earnings per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended
June 30, |
|
|
Six months ended
June 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| |
|
$ |
|
|
$ |
|
|
$ |
|
|
$ |
|
| Net Income (loss) attributable to shareholders |
|
|
(1,692,836 |
) |
|
|
1,499,975 |
|
|
|
(4,395,053 |
) |
|
|
2,098,757 |
|
| Weighted average number of SV Shares outstanding |
|
|
249,938,980 |
|
|
|
247,015,784 |
|
|
|
249,926,825 |
|
|
|
237,157,649 |
|
| Dilutive effect of stock options outstanding |
|
|
- |
|
|
|
1,925,170 |
|
|
|
- |
|
|
|
2,106,640 |
|
| Dilutive effect of RSU’s outstanding |
|
|
- |
|
|
|
1,668,375 |
|
|
|
- |
|
|
|
1,668,375 |
|
| Dilutive effect of warrants outstanding |
|
|
- |
|
|
|
2,313,504 |
|
|
|
- |
|
|
|
2,674,365 |
|
| Diluted weighted average number of SV Shares outstanding |
|
|
249,938,980 |
|
|
|
252,922,833 |
|
|
|
249,926,825 |
|
|
|
243,607,029 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic net income (loss) per share |
|
|
(0.01 |
) |
|
|
0.01 |
|
|
|
(0.02 |
) |
|
|
0.01 |
|
| Diluted net income (loss) per share |
|
|
(0.01 |
) |
|
|
0.01 |
|
|
|
(0.02 |
) |
|
|
0.01 |
|
|
| Schedule of anti-dilutive |
| Schedule of anti-dilutive |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three months ended
June 30, |
|
|
Six months ended
June 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| |
|
# |
|
|
# |
|
|
# |
|
|
# |
|
| Stock options |
|
|
14,015,000 |
|
|
|
- |
|
|
|
13,665,000 |
|
|
|
- |
|
| RSU’s |
|
|
1,496,500 |
|
|
|
- |
|
|
|
1,496,500 |
|
|
|
- |
|
| Warrants |
|
|
4,000,000 |
|
|
|
- |
|
|
|
4,000,000 |
|
|
|
- |
|
| Total |
|
|
19,511,500 |
|
|
|
- |
|
|
|
19,161,500 |
|
|
|
- |
|
|